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CD4+Foxp3+ regulatory T (T reg) cells are 
essential for the maintenance of self-tolerance, 
and T reg cell defi  ciency results in spontane-
ous autoimmunity in both mice and humans 
(1). T reg cells also control disease in several 
mouse models of organ-specifi  c autoimmu-
nity, including diabetes (2, 3), experimental 
autoimmune encephalomyelitis (4, 5), colitis (6), 
gastritis (7), and collagen-induced arthritis (8). 
Furthermore, CD25+ T reg cells ameliorate 
graft-versus-host disease (9, 10), and have been 
implicated in limiting immunopathology dur-
ing responses to foreign antigens, including in-
fectious agents such as Leishmania major (11) 
and infl  uenza (12). Although extensively stud-
ied, the mechanisms used by T reg cells to con-
trol T cell responses remain controversial, with 
both cell contact– and cytokine-dependent mech-
anisms invoked in various in vitro and in vivo 
settings (13). This suggests that T reg cells may 
use multiple mechanisms to limit autoimmu-
nity, and may refl  ect functional heterogeneity 
among T reg cell subsets that localize to distinct 
tissue environments.
Although the homing properties and in vivo 
distribution of T reg cells are still poorly charac-
terized, their appropriate localization is likely to 
be essential for their ability to prevent autoimmu-
nity. Both cell contact– and   cytokine-based im-
munosuppressive mechanisms would require that 
T reg cells be in close proximity to their targets. It 
therefore follows that T reg cells must colocalize 
with these cells in vivo to eff  ectively modulate 
their activities. In addition, T reg cell localization 
may be important for their access to survival and/
or proliferative factors that defi  ne a unique ho-
meostatic “T reg cell niche” (14).
In vivo, T reg cells express diverse patterns of 
homing receptors that are expected to target dis-
tinct subsets into a wide array of lymphoid and 
nonlymphoid sites (8, 15). Within the secondary 
lymphoid organs, T reg cells can block the initial 
priming and eff  ector diff  erentiation of auto-
reactive T cells. For instance, in a TCR transgenic 
mouse model of type 1 diabetes, transferred T 
reg cells inhibited the diff  erentiation of eff  ector 
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T cells in the LN and blocked their subsequent migration to 
the pancreatic islets (16). Furthermore, in NOD mice, the 
ability of transferred T reg cells to prevent diabetes depended 
on their expression of CD62L and their migration to LNs (2). 
More recently, in vivo imaging studies have demonstrated 
that within LNs, T reg cells appear to function by interacting 
with DCs and limiting their ability to eff  ectively prime naive 
T cells (17, 18).
Although the activity of   T reg cells within nonlymphoid 
sites is still poorly understood, expression of CD103 (also 
known as the αE integrin) has been suggested as a marker for 
“eff  ector memory” T reg cells that preferentially migrate to 
and function within these sites (8, 19). Indeed, several recent 
studies have implicated T reg cell activity in nonlymphoid 
  tissues in limiting peripheral infl  ammation and autoimmunity. 
In the BDC2.5 adoptive transfer model of diabetes, cotrans-
ferred T reg cells neither inhibited the initial activation and ex-
pansion of the BDC2.5 eff  ector T cells nor did they change the 
level of cellular infi  ltration of the pancreatic islets (20). Instead, 
their activity appeared to be restricted to controlling the pro-
gression and severity of islet destruction within the pancreas. 
Similarly, during L. major infection, CD103+ T reg cells 
migrated to the skin in a CCR5-  dependent manner, where 
they served to dampen the immune response to the pathogen 
(21, 22). T reg cell migration to nonlymphoid tissues was also 
required for their ability to prevent acute graft-versus-host 
disease and cardiac graft rejection (23, 24). Finally, migration of 
T reg cells to the skin was required for the amelioration of 
OVA-induced, delayed-type hypersensitivity responses (15). 
Although these data indicate that T reg cell migration into 
nonlymphoid tissues is essential during infl  ammatory responses 
to foreign antigens or in acute models of autoimmunity, this 
requirement does not appear to be absolute. For example, in an 
adoptive transfer model of colitis, T reg cells can prevent disease 
even when their migration to the colon is severely impaired (25). 
In addition, the importance of   T reg cells in maintaining toler-
ance in nonlymphoid tissues under steady state conditions has not 
been demonstrated.
A large fraction of T reg cells in human peripheral blood 
express the chemokine receptor CCR4 and display strong 
chemotactic responses to its ligands CCL17 and CCL22 
(26, 27). CCR4−/− mice fail to develop allograft tolerance 
after administration of anti-CD154 and donor spleen cells, and 
this is associated with decreased accumulation of Foxp3-express-
ing cells in the graft (23). Nevertheless, the role of CCR4 in 
directing T reg cell migration and function in vivo is still 
poorly understood. Outside of the thymus, the CCR4 ligand 
CCL17 is constitutively expressed by endothelial cells in dermal 
postcapillary venules and by bronchial epithelial cells (28, 29). 
In addition, both CCL17 and a second CCR4 ligand, CCL22, 
are expressed by activated B cells, by macrophages, and by 
several DC subsets (30–32). Therefore, T reg cells may de-
pend on the expression of CCR4 not only to localize in non-
lymphoid tissues such as the skin and the lungs but also to 
direct their migration to diff  erent populations of APCs within 
the secondary lymphoid tissues.
In this study, we examined how the tissue distribution of 
T reg cells is related to their ability to maintain immune tol-
erance and prevent infl  ammatory disease. We demonstrate 
that the majority of Foxp3+ T reg cells in most murine non-
lymphoid tissues are CCR4+ and that T reg cells in the skin 
have a unique CD103hiCCR4+ surface phenotype. Analysis 
of antigen-specifi  c T reg cells demonstrates that these cells 
up-regulate CCR4, CD103, and other skin-homing recep-
tors when they are stimulated by their cognate antigen within 
subcutaneous LNs under proinfl  ammatory conditions. Fur-
thermore, we show that CCR4 plays a role in the develop-
ment or survival of skin-tropic CD103hi T reg cells, and in 
the accumulation of T reg cells in the skin and lung airways. 
To assess the impact of altering the tissue and microenviron-
mental distribution of T reg cells, we constructed mixed 
BM chimeras in which complete loss of CCR4 is restricted 
to the Foxp3+ T reg cell compartment. In these animals, 
the lack of CCR4 expression on T reg cells resulted in pe-
ripheral lymphadenopathy, and in an increased frequency of 
CD4+Foxp3− T cells expressing skin-homing receptors. 
Moreover, these mice developed severe lymphocytic infi  ltra-
tion and infl  ammation in the skin and the lungs, whereas all 
other tissues examined remained normal. Thus, selectively 
perturbing the migration of T reg cells through removal of 
CCR4 impaired their ability to eff  ectively control CD4+ 
T cell activation and diff  erentiation and to prevent tissue-
  specifi  c infl  ammatory disease.
RESULTS
CCR4+ T reg cells are enriched in nonlymphoid tissues
The activity of T reg cells isolated from lymphoid tissues 
has been extensively characterized, but the presence and 
activity of these cells within nonlymphoid tissues is not well 
understood, particularly under noninfl  ammatory conditions. 
To determine if T reg cells are resident within nonlym-
phoid tissues, we analyzed CD4+ T cells isolated from Foxp3gfp 
mice (33). In these animals, GFP has been inserted in-frame 
upstream of the Foxp3 coding sequence, resulting in expres-
sion of a fully functional GFP-Foxp3 fusion protein. As a re-
sult, T reg cells can be easily identifi  ed on a single cell level in 
these animals via fl  ow cytometry. In the Foxp3gfp mice, there 
was a substantial population of CD4+GFP+ cells not only in 
secondary lymphoid tissues such as the spleen, subcutaneous 
peripheral LNs (PLN), mesenteric LNs (MLN), and Peyer’s 
patches, but also in all nonlymphoid tissues examined, includ-
ing the skin, lung, liver, peritoneal cavity, intestinal epithe-
lium, and intestinal lamina propria (Fig. 1 and not depicted). 
Thus, T reg cells are distributed throughout the body in a wide 
array of nonlymphoid tissues, even in the absence of any overt 
infl  ammatory responses.
Two surface homing receptors previously associated with 
T reg cell migration into nonlymphoid tissues are the chemo-
kine receptor CCR4 and the integrin CD103 (8, 23). We 
therefore examined expression of these molecules by T reg 
cells isolated from diff  erent organs. CCR4+ and CD103+ T 
reg cells were dramatically enriched in all nonlymphoid tissues JEM VOL. 204, June 11, 2007  1337
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examined, which is consistent with their proposed roles in di-
recting T reg cells to these sites (Fig. 1). Interestingly, nearly all 
GFP+ T reg cells in the skin expressed a unique CD103hiCCR4+ 
phenotype that was uncommon among T reg cells from all 
other tissues examined (Fig. 1, boxed gate). CCR4 has been 
implicated in the migration of CD4+ T cells to the skin and 
in the development and/or survival of skin-tropic CD4+ 
T cells that express CD103 and functional E-selectin ligands 
(E-lig) (34). Likewise, CD103 has been associated with T cell 
accumulation in epithelial sites, where its ligand E-cadherin 
is expressed. Therefore, the CD103hiCCR4+ phenotype of 
cutaneous T reg cells suggests that the coordinated activities of 
these molecules may be particularly important for the proper 
localization and function of T reg cells within the skin.
Peripheral recognition of self-antigen alters T reg cell 
tissue tropism
Naive CD4+ T cells exit the thymus expressing homing 
  receptors such as CD62L and CCR7, which mediate their 
continual recirculation through the various secondary lymphoid 
tissues. Upon stimulation with cognate antigen, T cells shift 
their tissue-tropism and acquire expression of homing recep-
tors that direct their migration into specifi  c nonlymphoid 
sites (35, 36). Similarly, T reg cells may up-regulate expression 
of CD103, CCR4, and other homing receptors that direct 
their entry into nonlymphoid tissues after recognition of self-
antigens in the secondary lymphoid tissues. To directly test 
this hypothesis, we examined OVA-specifi  c T reg cells from 
double transgenic DO11.10xRIP-mOVA mice. In these ani-
mals, OVA (driven by the rat insulin promoter) is expressed in 
both the thymus and in the pancreatic islets. As a result,  50% 
of the OVA-specifi  c transgenic T cells (identifi  ed by staining 
with the TCR clonotypic antibody KJ1-26) diff  erentiate into 
fully functional CD25+Foxp3+ T reg cells (37).
We transferred 105 FACS-sorted CD4+CD25+  CD103−-
CD62L+ T reg cells from DO11.10xRIP-mOVA mice into 
WT BALB/c recipients. Approximately 90% of the trans-
ferred cells were KJ1-26+ and expressed the LN homing 
Figure 1.   CD4+Foxp3+ T cells are resident in both lymphoid and 
nonlymphoid tissues. (fi  rst and third rows) Flow cytometry analysis of 
CD4 and GFP expression by lymphocytes isolated from the spleen, skin-
draining PLNs, MLNs, thymus, Peyer’s patches, skin, lung parenchyma, 
liver, and intestinal lamina propria of a 12-wk-old Foxp3gfp mouse. Per-
centage indicates the fraction of CD4+ cells expressing GFP. (second and 
fourth rows) Expression of CD103 and CCR4 by gated CD4+GFP+cells from 
each tissue. Percentage indicates the fraction of T reg cells that are 
CD103highCCR4+ as defi  ned by the rectangular gate in the upper right 
quadrant. For the CCR4-negative control, spleen cells were stained with 
CCL22-Fc fusion protein that was preincubated for 5 min with a neutral-
izing anti-CCL22 monoclonal antibody. Results are representative of 
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receptor CCR7, but were negative for expression of CCR4 
and the skin-homing receptor E-lig (Fig. 2 A). To mimic rec-
ognition of cutaneous self-antigen in diff  erent conditions, the 
recipient animals were immunized with 200 μg of soluble 
OVA by subcutaneous injection in PBS, either alone or in 
combination with 1 μg of cholera toxin (CT) as a proin-
fl  ammatory stimulus. Cells were harvested from the draining 
inguinal LNs 5 d after immunization, and homing receptor 
expression by the OVA-specifi  c T reg cells was assessed by 
fl  ow cytometry (Fig. 2 B). Upon stimulation with OVA+CT, 
the KJ1-26+ T reg cell underwent extensive expansion, and 
the vast majority became CD103hi. In addition, many of the 
CD103hi cells coexpressed CCR4 and E-lig, and nearly all 
cells down-regulated CCR7. Although many KJ1-26+ T 
reg cells also up-regulated CCR4 in response to soluble OVA 
alone, these cells did not expand as robustly without the 
proinfl  ammatory stimulus, and few up-regulated CD103 
or E-lig, whereas many retained expression of CCR7 and 
CD62L. Thus, after antigen recognition in the PLN under 
proinfl  ammatory conditions, the OVA-specifi  c T reg cells 
appear to have undergone a full program of diff  erentiation 
that resulted in a dramatic shift in their tissue tropism. This 
involved robust expansion, accompanied by acquisition of 
homing receptors required for migration to the skin and 
loss of a chemokine receptor critical for T cell homing into 
  secondary lymphoid organs. Indeed, 5 d after immunization 
with OVA+CT, CD4+KJ1-26+ T cells had migrated to the 
infl  amed skin overlaying the injection site (unpublished data). 
In contrast, a large fraction of T reg cells activated by solu-
ble antigen alone appeared to retain their preferential tro-
pism for the secondary lymphoid organs. Importantly, after 
immunization with either OVA or OVA+CT, >95% of the 
KJ1-26+ cells remained Foxp3+, indicating that immuniza-
tion under these conditions did not alter their functional status 
as T reg cells (Fig. S1, available at http://www.jem.org/cgi/
content/full/jem.20070081/DC1).
T reg cell accumulation in the skin and lungs is impaired 
in the absence of CCR4
To determine if CCR4 has a role in T reg cell develop-
ment or localization, we constructed mixed BM chimeras 
using congenically marked CCR4−/− (CD45.2+) and WT 
B6.SJL  (CD45.1+) donors. We then determined if specifi  c 
subsets of T reg cells were at a competitive disadvantage 
caused by their lack of CCR4, and whether CCR4−/− T 
reg cells accumulated in various tissues as effi   ciently as their 
WT counterparts.
In the spleens of the mixed BM chimeras, the ratio of 
Foxp3+ T reg cells from the CCR4−/− and WT donors was 
similar to that observed for total CD4+ T cells, indicating that 
Figure 2.  T reg cells alter their tissue tropism after antigen 
stimulation. (A) Flow cytometry analysis of CD62L and CD103 expression 
by gated CD4+CD25+ cells from the pooled spleen and PLN of a DO11.
10xRIP-mOVA mouse before and after sorting of CD62L+CD103− cells 
(left). (right) Expression of the DO11.10 clonotypic TCR (KJ1-26), E-selectin 
ligand, CCR4, and CCR7 by the sorted CD62L+CD103− T reg cells. (B) Flow 
cytometry analysis of lymphocytes from the draining inguinal LNs of 
recipient mice 5 d after immunization with OVA+CT (top) or OVA alone 
(bottom). (left) Gates used to defi  ne the OVA-specifi  c T reg cells. Percent-
ages indicate the frequency of KJ1-26+ cells among total CD4+ cells. 
(right) Expression of CD103, E-selectin ligand, CCR4, and CCR7 by gated 
CD4+KJ1-26+ cells.JEM VOL. 204, June 11, 2007  1339
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there was no gross developmental disadvantage for CCR4−/− 
T reg cells (unpublished data). However, within the subcu-
taneous PLN, T reg cells expressing high levels of CD103 
were predominately derived from the WT donor (Fig. 3 A). 
For each animal analyzed, we normalized the ratio of WT/
CCR4−/− cells among the CD103hi T reg cells in the PLN 
by the ratio found among total splenic T reg cells. On av-
erage, the ratio among the CD103hi cells was approximately 
threefold higher than the ratio in the spleen, indicating a clear 
developmental or survival advantage for WT cells in this com-
partment (Fig. 3 B). A similar threefold increase in the ratio 
of WT/CCR4−/− cells was observed among E-lig+ T reg cells 
in the PLN (unpublished data), which is consistent with the 
preferential expression of E-lig by CD103hi cells after antigen 
stimulation of OVA-specifi  c T reg cells (Fig. 2 B). In con-
trast, the ratio of WT/CCR4−/− cells within the CD103low 
and CD103-negative populations of T reg cells in the PLN, 
or in any T reg cell populations examined in the MLN, was 
nearly identical to that found among T reg cells in the spleen 
(Fig. 3 B and not depicted).
Because CCR4 is expressed by most T reg cells in 
nonlymphoid tissues, we also examined the ratio of WT/
CCR4−/− T reg cells in the skin, liver, and lung airways of 
the chimeric mice. Similar to their CD103hi counterparts in 
the PLN, we found that cutaneous T reg cells were largely 
of WT origin, with a normalized ratio approximately three-
fold higher than that found among T reg cells in the spleen. 
Surprisingly, among all tissues and T reg cell subsets exam-
ined,  the highest ratio of WT/CCR4−/− cells was found 
among T reg cells isolated from the lung airways, with a mean 
ratio approximately sixfold higher than splenic T reg cells. In 
contrast, there was only a slight (approximately twofold) pref-
erence for WT cells among T reg cells isolated from the livers 
of these mice that, when compared with the ratio of WT/
CCR4−/− cells found in CD103− T reg cells from the PLN, 
did not reach statistical signifi  cance. From these data, we con-
clude that in the absence of CCR4, the development and/or 
survival of cutaneous CD103hi T reg cells is impaired, and 
there is a reduced accumulation of T reg cells in the skin and 
lung airways.
Figure 3.  Impaired accumulation of CCR4−/− T reg cells in the skin 
and lung airways. (A) Representative fl  ow cytometry analysis of CD45.1 
expression by gated CD4+Foxp3+ cells from the indicated tissues of a 
WT+CCR4−/− mixed BM chimera. WT cells are CD45.1+. (B) The normal-
ized ratio of WT to CCR4−/− T reg cells in the indicated tissues/compart-
ments was derived by dividing the ratio of WT/CCR4−/− T reg cells in each 
by the ratio of WT/CCR4−/− T reg cells in the spleen. Each data point rep-
resents the normalized ratio from one individual chimera. Horizontal lines 
indicate the average normalized ratio (n = 5) in each tissue/compartment. 
Statistical analysis was performed using a one-way repeated measures 
ANOVA (P < 0.0001). P-values for the indicated pairwise comparisons 
were then computed using Dunnett’s Multiple Comparison Test.
Figure 4.  Schematic of mixed BM chimera experimental setup and 
Foxp3+ T cell development. (A) Schematic representation of mixed BM 
chimera experimental set-up. (B) Representative fl  ow cytometry analysis 
of CD45.1 and Foxp3 expression by gated CD4+ T cells from the PLN of 
one pair of CCR4/sf and WT/sf chimeras killed 153 d after BM transplant.1340  CCR4 AND FOXP3+ REGULATORY T CELL MIGRATION | Sather et al.
Lack of CCR4 expression on T reg cells results in cutaneous 
and pulmonary infl  ammation
The impaired accumulation of CCR4−/− T reg cells in 
the skin and lung airways suggests that this receptor helps di-
rect T reg cell migration to these sites in vivo. However, 
CCR4−/− mice do not develop any spontaneous infl  amma-
tory disease indicative of a defect in T reg cell function (38). 
This may be because migration of both T reg cells and 
Foxp3− eff  ector memory CD4+ T cells are similarly impaired 
in these animals. Consistent with this notion, in the WT/
CCR4−/− mixed BM chimeras, we found that the accumu-
lation of both Foxp3+ and Foxp3− CD4+ T cells in the skin 
and lung airways was similarly impaired in the absence of 
CCR4 (Fig. 3 and Fig. S2, available at http://www.jem.org/
cgi/content/full/jem.20070081/DC1). Therefore, to assess 
the importance of CCR4 for T reg cell localization and func-
tion in the context of a largely WT Foxp3− T cell compart-
ment, we constructed mixed BM chimeras by transferring 
BM from CD45.1+ Foxp3-defi  cient scurfy (sf) mice (39) and 
CD45.2+ CCR4−/− mice into irradiated RAG1−/− recipi-
ents (Fig. 4 A). In the resulting chimeras, only the CCR4−/− 
cells can give rise to Foxp3+ T reg cells, whereas all other 
T cell compartments are a mixture of CCR4+/+ and CCR4−/− 
cells. As controls, irradiated RAG−/− mice were reconsti-
tuted with BM from sf and WT CD45.2+ mice, or with sf BM 
alone. Hereafter, these mice will be referred to as CCR4/sf, 
WT/sf, and sf chimeras. In both CCR4/sf and WT/sf chimeras, 
normal numbers of lymphocytes develop and populate the 
periphery after BM reconstitution. Furthermore, as expected, 
all T reg cells developed from the CD45.2+CD45.1− CCR4−/− 
or WT donor cells (Fig. 4 B).
All chimeras that received only sf BM developed severe 
dermatitis and wasting, and were killed by 40 d after trans-
plantation. Histological analysis of these animals revealed 
extensive infl  ammatory disease in the skin, lungs, and liver, 
which are the three major target tissues of autoimmunity in sf 
mice (Fig. 5 A, bottom). In contrast, the WT/sf chimeras re-
mained phenotypically normal for up to 300 d after transfer, 
and showed little or no infl  ammatory disease in all tissues ex-
amined (Fig. 5 A, middle). Therefore, WT T reg cells were 
able to suppress the infl  ammatory disease caused by sf-derived 
CD4+ T cells. However, all CCR4/sf chimeras developed 
severe localized skin infl  ammation that was visible 50–150 d 
after transplantation. When cutaneous infl  ammatory disease 
became severe, with visible crusting, alopecia, and erythema 
in aff  ected regions, each CCR4/sf chimeras was killed and 
analyzed along with a WT/sf counterpart (100–250 d after 
BM transplant). Within aff  ected areas of the skin, there was 
extensive mixed leukocytic infi  ltration of the dermis ac-
companied by marked epidermal hyperplasia (Fig. 5 A, top). 
Infl  ammatory dermal infi  ltrates were composed largely of 
lymphocytes, neutrophils, eosinophils, and mast cells (Fig. 
S3, available at http://www.jem.org/cgi/content/full/jem
.20070081/DC1). In addition, there was signifi  cant, albeit 
less severe, lymphocytic infi  ltration and infl  ammatory disease 
in the lungs, which was concentrated around the blood vessels 
and large airways (Fig. 5 A, arrows). To quantify disease sever-
ity in these mice, we developed a histological scoring system 
based on the severity and overall distribution of infl  ammatory 
infi  ltrates within each tissue section. Blinded analysis of sec-
tions from the skin, lungs, and livers from a panel of CCR4/sf- 
and WT/sf chimeras revealed that the ability of CCR4−/− 
T reg cells to prevent infl  ammatory disease in the skin and 
lungs is signifi  cantly impaired (Fig. 5 B). In contrast, WT and 
CCR4−/− T reg cells were both capable of preventing the 
extensive infl  ammatory hepatitis that developed in animals 
receiving only sf BM.
Consistent with the cutaneous infl  ammation observed in 
the CCR4/sf chimeras, these mice displayed severe lymph-
adenopathy selectively in the subcutaneous PLN (Fig. 6 B). 
This suggests that the CCR4−/− T reg cells failed to effi   ciently 
control the activation and diff   erentiation of the sf-  derived 
Figure 5.  Infl  ammatory disease in the skin and lungs of CCR4/sf 
chimeras. (A) Photomicrographs (20×) of hematoxylin and eosin–stained 
sections of the skin, lung, and liver from CCR4/sf, WT/sf (killed 114 d after 
BM transplant), or sf only chimeras (killed 38 d after BM transplant). 
Green arrows indicate the location of infl  ammatory infi  ltrates in the lungs 
of CCR4/sf and sf chimeras. (B) Blinded analysis of tissue sections from 
seven pairs of CCR4/sf and WT/sf chimeras (all killed in pairs 114–250 d 
after BM transplant). Each section was scored based on the severity and 
extent of infl  ammation. Statistical analysis was performed using two-
tailed, paired Student’s t test. ns, not signifi  cantly different (P > 0.05). 
Bars, 100 μm.JEM VOL. 204, June 11, 2007  1341
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CD4+ T cells. Indeed, phenotypic analysis of the CD4+
CD45.1+ sf-derived T cells in the PLN showed a signifi  cantly 
increased frequency of CD44hiCD45RBlow eff  ector memory 
cells when compared with cells from WT/sf chimeras (Fig. 
6 B). T cells activated in cutaneous LNs up-regulate skin-
homing receptors, such as P-selectin ligand (P-lig), E-lig, and 
CCR4 (35, 40). Accordingly, there was a signifi  cant increase 
in the fraction of sf-derived CD4+ T cells expressing these 
receptors in the cutaneous PLN of the CCR4/sf chimeras 
(Fig. 7). This accumulation of activated, skin-tropic CD4+ 
T cells in the PLN of CCR4/sf chimeras suggests that these 
cells migrated to the skin and mediated the cutaneous in-
fl  ammation observed in these animals. Indeed, in both the 
infl  amed and histologically normal skin of the CCR4/sf chi-
meras, there was a substantial accumulation of CD4+CD45.1+ 
sf-derived T cells that was not found in the phenotypically 
normal WT/sf chimeras (Fig. S4, available at http://www.jem
.org/cgi/content/full/jem.20070081/DC1, and not depicted). 
Consistent with the pulmonary infl  ammation in the CCR4/
sf chimeras, CD45.1+ T cells were also enriched in the both 
the lung airways and parenchyma of these mice. In addition, 
among CD4+ T cells in the skin and lung airways, there was 
a 3–4-fold reduction in the fraction of Foxp3+ T reg cells in 
the CCR4/sf chimeras compared with their WT/sf controls 
(unpublished data).
Adoptive transfer of purifi  ed CD4+CD25+ T reg cells 
into neonatal sf mice prevents the development of systemic 
autoimmune and infl  ammatory disease in these animals (14). 
Therefore, to further assess the importance of CCR4-dependent 
localization of T reg cells in vivo, we compared the ability of 
WT and CCR4−/− T reg cells to rescue animals from disease 
in this model. Whereas WT T reg cells eff  ectively prevented 
infl  ammatory disease in all tissues examined, sf mice given 
CCR4−/− T reg cells developed a histological and cellular 
phenotype similar to the CCR4/sf chimeras, which was 
  visibly apparent after 50 d of age, with severe infl  ammatory 
disease evident in the skin and lungs, but not the liver (Fig. 8 
and not depicted). Thus, the cutaneous and pulmonary in-
fl  ammation in the CCR4/sf chimeras is not simply a byprod-
uct of the proinfl  ammatory eff  ects of the lethal irradiation 
used to condition the recipients, and it is not caused by the 
lymphopenia present in these animals. In addition, confi  rm-
ing previous results (23), we found that CCR4−/− T reg cells 
were as effi   cient as WT T reg cells at suppressing the prolif-
eration of CD4+ T cells in vitro, indicating that there is not 
a gross defect in the function of CCR4−/− T reg cells (Fig. 
S5, available at http://www.jem.org/cgi/content/full/jem
.20070081/DC1). Instead, our data demonstrate that altering 
the tissue and/or microenvironmental distribution of T reg 
cells by selective removal of CCR4 leads to excessive activa-
tion and diff  erentiation of CD4+ T cells in the PLN and their 
subsequent accumulation in the skin and lungs, resulting in 
the development of tissue-specifi  c infl  ammatory disease.
D  I  S  C  U  S  S  I  O  N 
The regulation of immune responses by T reg cells in vivo is 
a complex process, involving multiple T reg cell subsets that 
appear to use unique functional mechanisms to suppress the 
activation, diff  erentiation, and function of eff  ector T cells 
within both lymphoid and nonlymphoid tissues. We exam-
ined the tissue distribution of T reg cells in the steady state, 
and determined the impact of altering this distribution by re-
moval of the chemokine receptor CCR4. Our results have 
several important implications for current models of T reg 
cell migration and function.
Early studies of T reg cells suggested they predominantly 
functioned within secondary lymphoid tissues by inhibiting 
the initial priming of autoreactive T cells (1). However, data 
from several models have now convincingly demonstrated that 
T reg cells can also regulate eff  ector T cell responses to both 
self- and foreign antigens during acute infl  ammation at non-
lymphoid sites (41). Although T reg cells have been isolated 
from normal human skin and intestines (27, 42), their role 
in maintaining immune homeostasis in nonlymphoid sites 
under steady state conditions is not clear. Our analysis of T reg 
cell distribution in the Foxp3gfp mice further demonstrates 
that T reg cells are present within a wide variety of nonlym-
phoid organs, even in the absence of any overt infl  ammatory 
Figure 6.  Peripheral lymphadenopathy and enhanced CD4+ T cell 
activation in CCR4/sf chimeras. (a) Lymphocytes were isolated and 
counted from the spleen, subcutaneous PLNs, and MLNs of a matched 
group of three CCR4/sf chimeras (squares) and three WT/sf chimeras 
(triangles) killed 140 d after BM transplant. Data are representative of six 
experiments. Statistical analysis was performed using a two-tailed, 
 unpaired  Student’s  t test. (b) Representative fl  ow cytometry analysis of 
CD44 and CD45RB expression by gated CD4+CD45.1+ sf-derived T cells 
from the PLN of one pair of WT/sf and CCR4/sf chimeras killed 140 d after 
BM transplant. (right) The frequency of CD44hi cells amongst gated 
CD4+CD45.1+ PLN cells from nine matched pairs of WT/sf- and CCR4/sf 
chimeras (killed 114–250 d after BM transplant). Statistical analysis was 
performed using a two-tailed, paired Student’s t test.1342  CCR4 AND FOXP3+ REGULATORY T CELL MIGRATION | Sather et al.
response. This suggests that T reg cells constitutively function 
to help maintain immune tolerance and prevent autoimmunity 
at these sites.
The integrin CD103 has been proposed as a marker of 
eff  ector memory T reg cells with tropism for nonlymphoid 
tissues (8). Our analysis of T reg cells in Foxp3gfp animals 
demonstrated that CD103+ T reg cell are present at a higher 
frequency in nonlymphoid tissues than in the LNs, spleen, 
and Peyer’s patches. However, within most nonlymphoid 
compartments we examined, including the lungs, liver, intes-
tinal lamina propria, and intestinal epithelium, we found a 
mixture of both CD103+ and CD103− T reg cells. Thus, ex-
pression of CD103 alone cannot be used to defi  ne T reg cells 
with nonlymphoid tissue tropism. However, T reg cells iso-
lated from the skin did uniformly express very high levels of 
CD103, the expression of which may be selectively induced 
after their migration into the skin. CD103 has previously 
been associated with cutaneous T cells (43), and the CD103 
ligand E-cadherin is expressed by epidermal keratinocytes 
(44). Analogous to its proposed role in retaining T cells in 
the intestinal epithelium, CD103 may also facilitate T reg cell 
r  etention in the epidermis. This is consistent with the obli-
gate function of CD103 in T reg cell–mediated immune reg-
ulation during cutaneous L. major infection (21), and suggests 
that the CD103hi subset of T reg cells is phenotypically spe-
cialized to localize to and function within the skin. Indeed, 
Figure 7.  CCR4/sf chimeras have an elevated frequency of skin-
tropic CD4+ T cells. (top) Representative fl  ow cytometry analysis of 
CCR4, P-selectin ligand, and E-selectin ligand expression by gated 
CD4+CD45.1+ sf-derived T cells from the PLN of WT/sf and CCR4/sf 
chimeras (open area) killed 140 d after BM transplant. Shaded areas of the 
graph indicate background staining in the presence of anti-CCL22 (left)
or 10 mM EDTA (middle and right). (bottom) Graphs indicating the fre-
quency of gated CD4+CD45.1+ cells expressing the indicated receptor in 
the PLNs of fi  ve matched pairs of WT/sf- and CCR4/sf chimeras (all killed 
114–250 d after BM transplant). Statistical analysis was performed using 
a two-tailed, paired Student’s t test.
Figure 8.  CCR4−/− T reg cells fail to prevent cutaneous and pul-
monary infl  ammation after transfer into neonatal sf mice. Photo-
micrographs of hematoxylin and eosin–stained sections of skin, lung, and 
liver from either an unmanipulated sf mouse (bottom) or from sf mice 
given purifi  ed WT or CCR4−/− CD4+CD25+ T reg cells (top and middle) 
shortly after birth. Data are representative of more than eight mice ana-
lyzed in each group. Bars, 100 μmJEM VOL. 204, June 11, 2007  1343
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the phenotypic diversity of T reg cells resident in diff  erent 
tissues further supports the concept that the T reg cell popu-
lation as a whole is made up of numerous subsets, each ex-
pressing diff  erent combinations of homing receptors that act 
to deliver specifi  c immunoregulatory functions to distinct tis-
sue sites in vivo.
Our analyses of OVA-specifi  c T reg cells demonstrated 
that T reg cells acquire the ability to migrate to nonlymphoid 
sites after the recognition of cognate antigen in the secondary 
lymphoid tissues, and that addition of a proinfl  ammatory 
stimulus greatly augmented this shift in T reg cell tissue tro-
pism. Most subsets of APC undergo a low level of constitutive 
traffi   cking from nonlymphoid tissues into the corresponding 
draining LNs. Once there, they can present self-antigens they 
have acquired to the largely autoreactive T reg cell population 
(45). We propose that when T reg cells recognize self-antigen 
presented by immature APCs during these noninfl  ammatory 
conditions (such as those found after administration of soluble 
antigen in our adoptive transfer model), they largely maintain 
their tropism for the secondary lymphoid tissues, where they 
function to suppress the initial priming and diff  erentiation of 
self-reactive T cells. However, during a strong tissue infl  am-
matory response (such as that induced by addition of CT in 
our model), T reg cells undergo extensive expansion, during 
which they acquire the ability to migrate to nonlymphoid 
tissues. This most likely occurs because of the increased mi-
gration of fully mature APCs to the draining LN. These APCs 
bear a wide range of T cell costimulatory molecules and can 
drive T reg cell expansion and diff  erentiation. After migration 
to nonlymphoid sites, T reg cells can limit eff  ector T cell re-
sponses, resulting in eff  ective pathogen control without cor-
responding collateral tissue damage and immunopathology. 
This type of peripheral immune regulation may be especially 
important in tissues such as the skin, lungs, and intestines, 
which are frequently bombarded with foreign antigens and 
“pathogen-associated molecular patterns” that eff  ectively ac-
tivate APC. Consistent with this notion, we found that an un-
usually large fraction (20–40%) of CD4+ T cells in normal 
skin are Foxp3+ T reg cells (Fig. 1 and not depicted), suggest-
ing that they have a critical function in preventing cutaneous 
infl  ammatory disease. Similarly, Foxp3+ T reg cells have been 
isolated from normal human skin, and a high proportion of 
T reg cells in human peripheral blood express cutaneous hom-
ing receptors (27). The skin and lungs (along with the liver) 
are primary targets of autoimmunity in Foxp3-defi  cient 
sf mice (39, 46), whereas humans defi  cient in FOXP3 expres-
sion and mice that lack T reg cells caused by mutations in 
various components of the IL-2 pathway generally develop 
severe enteropathy (47–49). Thus, Foxp3+ T reg cells appear 
to have a particularly important function in preventing auto-
immune and infl  ammatory disease in these barrier tissues.
The chemokine receptor CCR4 has previously been as-
sociated with T reg cell activity in both humans and mice 
(23, 26). In humans, CCR4 is expressed by most E-selectin 
ligand+ skin-tropic CD4+ T cells found in peripheral blood, 
and by nearly all CD4+ T cells isolated from normal skin 
(28, 50). Accordingly, CCR4 helps direct CD4+ T cells to the 
skin during responses to protein antigens and haptens in mice 
(51, 52). In addition, by constructing mixed BM chimeras 
  using WT and CCR4−/− mice as donors, Baekkevold et al. 
demonstrated that CCR4 plays a substantial role in the devel-
opment and/or survival of cutaneous CD103+E-lig+ CD4+ T 
cells (34). In similar mixed chimeras, we confi  rmed these results 
(Fig. S2), and additionally demonstrated that the vast majority 
of CD103hi or E-lig+ T reg cells present in the skin-draining 
LNs were derived from the WT donor. Furthermore, both T 
reg cells and CD4+Foxp3− T cells in the skin of these animals 
were predominantly of WT origin (Fig. 3 and Fig. S2). Thus, 
our results confi  rm the role of CCR4 in the optimal accumu-
lation of CD4+ T cells in the skin, and demonstrate that this re-
quirement applies to both conventional CD4+Foxp3− T cells 
and to Foxp3+ T reg cells.
Surprisingly, loss of CCR4 also severely impaired the ac-
cumulation of both Foxp3+ and Foxp3− CD4+ T cells in the 
lung airways. The CCR4 ligand CCL17 is constitutively ex-
pressed in the lungs by bronchial epithelial cells and CD11c+ 
APCs (29, 32). Additionally, expression of both CCL17 and 
CCL22 is strongly up-regulated in the lungs during pulmo-
nary infl  ammation (29, 53). Although CCR4 is expressed 
by nearly all CD4+ T cells recovered after bronchoalveolar 
lavage in humans, and at lower levels by most CD4+ cells 
isolated from human lung parenchyma (54), the function of 
this receptor in CD4+ T cell traffi   cking to the lungs remains 
poorly understood. Our results support a model in which 
CCR4 plays a signifi  cant role in the constitutive migration of 
CD4+ T cells to the lung airways. In addition, similar to the 
impaired development or survival of CD103hiE-lig+ skin-
tropic T cells, loss of CCR4 may also impair the generation 
of “lung-tropic” CD4+ T cells, further contributing to their 
failure to accumulate in the lung airways.
Colocalization of T reg cells with their targets is thought 
to be important for their suppressive function in vivo. By con-
structing mixed BM chimeras using CCR4−/− and Foxp3-
defi  cient sf mice as donors, we were able to determine how 
altering the distribution of T reg cells in vivo impacts their 
ability to prevent tissue-specifi  c infl  ammatory disease. Indeed, 
the phenotype of the CCR4/sf chimeras is indicative of mul-
tiple roles for CCR4 in T reg cell migration and function. 
Within the secondary lymphoid tissues, T reg cells can modu-
late the ability of APCs to eff  ectively prime naive T cells (17, 18). 
Upon maturation, many APC subsets produce both CCL17 
and CCL22, and this may help attract recently activated 
CCR4+ T cells for further activation (30, 55, 56). Notably, 
compared with splenic DCs, both CCL17 and CCL22 are 
expressed at particularly high levels by epidermal Langerhans 
cells (LCs) upon their maturation and migration to the skin-
draining LNs (57, 58). CCR4 may therefore play an impor-
tant role in guiding T reg cells to LCs and other cutaneous 
APC subsets within the PLN. During T cell priming, LCs 
potently induce CD4+ T cell expression of skin homing re-
ceptors, such as P- and E-lig (40). Thus, if CCR4−/− T reg 
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LCs, we expect that this would result in uncontrolled activa-
tion and diff  erentiation of skin-specifi  c autoreactive eff  ec-
tor T cells. This is consistent with the selective peripheral 
lymphadenopathy and increased frequency of sf-derived 
CD4+CD44hiCD45RBlo skin-tropic cells observed in the 
CCR4/sf chimeras. Thus, we propose that impaired T reg cell 
function within the PLN and the ineffi   cient localization of 
CCR4−/− T reg cells to the skin both contributed to the se-
vere cutaneous infl  ammation that developed in the CCR4/sf 
chimeras and in neonatal sf mice that received CCR4−/− T 
reg cells. Similarly, the pulmonary infl  ammation that devel-
oped in these animals was most likely caused by impaired 
T reg cell migration to the lung airways, and a corresponding 
failure to limit eff  ector T cell function at this site.
Despite the fact that CCR4 is expressed by most T reg cells 
in all nonlymphoid tissues we examined from the Foxp3gfp mice, 
T reg cell-mediated protection of tissues other than the skin 
and lungs appeared to function normally, even in the absence 
of this receptor. However, among nonlymphoid tissues in 
  unmanipulated mice, constitutive expression of CCL22 and/
or CCL17 is largely restricted to the skin and lungs (31, 32). 
Because we have shown that CCR4 is rapidly up-regulated by 
T reg cells upon antigen recognition, even in the absence of in-
fl  ammation, the high frequency of CCR4+ T reg cells in other 
nonlymphoid tissues may simply refl  ect continual stimulation 
of T reg cells by self-antigen at these sites.
The critical function of T reg cells in maintaining im-
mune tolerance in vivo has been fi  rmly established. Indeed, 
acute depletion of T reg cells in adult mice leads to rapid de-
velopment of systemic lymphadenopathy and splenomegaly 
accompanied by severe multiorgan infl  ammation, indicating 
that T reg cell–mediated immune suppression is critical 
throughout life (59). Our data demonstrate that T reg cells 
are found in a wide variety of lymphoid and nonlymphoid 
organs, and that simply altering the tissue and microenviron-
mental distribution of T reg cells results in tissue-specifi  c in-
fl  ammatory disease. This indicates that the balance of T reg 
cells and eff  ector T cell activities in diff  erent tissues are pre-
cisely tuned to allow for eff  ective immunosurveillance and 
pathogen control, while preventing the development of 
chronic infl  ammatory and autoimmune diseases. In addition, 
the possibility that subsets of T reg cells are phenotypically 
specialized to function in specifi  c tissues is important to con-
sider when designing therapies involving T reg cell manipu-
lation or enrichment.
MATERIALS AND METHODS
Animals. C57BL/6J, BALB/cJ, RAG−/− (B6.129S7-Rag1tm1Mom/J), and 
DO11.10 (C.Cg-Tg[DO11.10]10Dlo/J) mice were purchased from The 
Jackson Laboratory. CD45.1+ B6.SJL mice (B6.SJL-Ptprca/BoyAiTac) were 
purchased from Taconic Farms. Scurfy mice (B6.Cg-Foxp3sf/J) were ob-
tained from The Jackson Laboratory and crossed to B6.SJL mice to generate 
CD45.1+ animals. CCR4−/− mice on the C57BL/6 genetic background 
were obtained from S. Ziegler (Benaroya Research Institute, Seattle, WA). 
Foxp3GFP mice have been described previously (33). BALB/c mice express-
ing RIP-mOVA were provided by A. Abbas (University of California, San 
Francisco, San Francisco, CA). All animals were housed and bred under 
specifi  c pathogen-free conditions in the Benaroya Research Institute animal 
facility. All experiments were approved by the Benaroya Research Institute 
Institutional Animal Care and Use Committee
Cell isolation. After whole-body perfusion with 50 ml of heparinized PBS, 
lymphocytes were isolated as follows. Single-cell suspensions were prepared 
from thymus, spleen, PLNs (pooled inguinal, axillary, brachial, and superfi  -
cial cervical nodes), and MLNs by tissue disruption with glass slides, and fi  l-
tered thru a 40-μM fi  lter. Bronchoalveolar lavage fl  uid was collected by 
fl  ushing the lungs with 10 ml cold sterile PBS. To isolate cells from the liver, 
lung, and skin (after removal of subcutaneous fat by scraping), tissues were 
fi  nely minced with scissors and vigorously stirred in RPMI with 0.14 U/ml 
Blendzyme (Roche) and 100 μg/ml DNase I (Roche) for 20 min at 37°C. 
Supernatants were fi  ltered through a 70-μM cell strainer, and the remaining 
tissue fragments were digested twice more, pooling all released cells. After 
dissection and removal of Peyer’s patches, intestinal lamina propria lympho-
cytes (LPL) were isolated as follows. The intestinal epithelium was stripped, 
as previously described (60, 61), and the remaining intestinal pieces were 
washed three times in 40 ml of cold RPMI. Intestinal pieces were added to 
50 ml of RPMI plus 100 μl 0.5 M MgCl2, 100 μl 0.5 M CaCl2, 500 μl 
100× HGPG (111.9 mg/ml Hepes, 29.2 mg/ml L-glutamine, 1,000 U/ml 
penicillin, 1 mg/ml streptomycin, and 10 mg/ml gentamycin, all purchased 
from Invitrogen), and 150 U/ml collagenase (Roche). Samples were stirred 
at 37°C for 1 h, and the released cells were then fi  ltered through nitex. Cells 
isolated from the skin, lung, liver, and lamina propria were pelleted, resus-
pended in 44% Percoll (GE Healthcare) in RPMI, layered over 67% Percoll, 
and spun at 2,800 rpm for 20 min. Lymphocytes were isolated from the 
interface and used for subsequent fl  ow cytometry analyses.
Flow cytometry. For cell-surface staining, 106 cells per sample were incu-
bated with various antibodies in staining buff  er (HBSS and 3% FCS) for 
20 min on ice. Anti-murine antibodies included: anti-CD25 (PC61.5), anti-
CD4 (RM4-5), anti-CD62L (MEL-14), anti-CD44 (IM7), anti-CD45RB 
(C363.16A), anti-CD45.1 (A20), anti-CD45.2 (104), anti-DO11.10 TCR 
(KJ1-26), and anti-CD103 (2E7); all antibodies were obtained from eBio-
science. To assess the expression of CCR4 and CCR7, cells were incubated 
with CCL22- or CCL19-IgG3 fusion proteins, followed by anti–human 
IgG-APC (Jackson ImmunoResearch Laboratories). To assess expression of 
functional P- and E-selectin ligands, cells were sequentially incubated with 
either a P- or E-selectin–human IgM fusion protein (produced in COS-7 
cells), followed by biotinylated goat anti–human IgM (Jackson Immuno
Research) and streptavidin–PE (eBioscience). Foxp3 expression was assessed 
by staining with anti-Foxp3 (FJK-16s; eBioscience) according to the manu-
facturer’s protocol. Data were acquired on a FACsCalibur (BD Biosciences) 
and analyzed using FlowJo software (Tree Star).
Adoptive transfer and immunization. CD4+CD25+CD62L+CD103− 
T reg cells were isolated from the spleen and PLNs of 5-wk-old double-
transgenic DO11.10xRIP-OVA mice by FACS. BALB/c mice were given 
105 sorted T reg cells by retroorbital injection in 100 μl of PBS. 1 d after 
transfer, the recipient mice were immunized by subcutaneous injection un-
der the abdominal skin with 200 μg OVA, either alone or in conjunction 
with 1 μg CT in 100 μl PBS. 5 d after immunization, mice were killed, and 
lymphocytes were isolated from the draining inguinal LNs for analysis by 
fl  ow cytometry.
BM chimeras. BM cells were prepared by fl  ushing the femurs and tibias 
with cold sterile PBS. The cells were fi  ltered through a 40-μM fi  lter and 
i  ncubated in hemolytic buff  er for 2 min at room temperature. CD4+ cells 
were depleted from sf-derived BM by magnetic depletion using anti-CD4 
microbeads (Miltenyi Biotech), and they contained <1% contaminating 
CD4+ T cells after depletion. The cells were counted, washed, resuspended 
in sterile PBS, and injected retroorbitally into anesthetized RAG−/− mice 
(6–12 wk old) that had received 2 doses (separated by 4 h) of 450 Rad from 
a cesium irradiator. Recipients were given 2 × 106 CD4-depleted BM cells JEM VOL. 204, June 11, 2007  1345
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from sf donors, either alone or mixed with 106 CCR4−/− or WT BM cells. 
For the WT/CCR4−/− mixed chimeras, Rag−/− recipients received 3 × 106 
of a 1:1 mixture of WT (CD45.1+) and CCR4−/− (CD45.2+) BM cells.
Tissue histology. Tissues were immersion fi  xed in 10% neutral buff  ered 
formalin, paraffi   n embedded, and cut into 5 μm sections, which were stained 
with hematoxylin and eosin. All tissue sections were examined by a blinded 
observer for infl  ammatory infi  ltrates and scored for severity (normal, mini-
mal, mild, moderate, and severe) and degree of distribution (focal, focally 
extensive, multifocal, coalescing, and diff  use) in diff  erent subregions of each 
tissue (see Table S1, available at http://www.jem.org/cgi/content/full/jem
.20070081/DC1, for additional details). Each region was then assigned a 
subscore by multiplying the infl  ammation severity score by the distribution 
score. These subscores were then summed to generate a total histological 
score for each section.
In vitro suppression assay. CD4+ T cells were isolated from the spleen 
and LNs of WT or CCR4−/− mice by negative selection with a Dynal CD4 
T cell–negative isolation kit (Invitrogen). These cells were further separated 
into CD25+ and CD25− fractions by staining with CD25-PE, and by mag-
netic fractionation using anti-PE magnetic microbeads (Miltenyi Biotech). 
Final suspensions of CD4+CD25+ and CD4+CD25− cells were >90% pure. 
CD4+CD25− cells were incubated for 9 min at 37°C in 0.8 μM CFSE 
  (Invitrogen) in PBS, washed with 100% FBS, and resuspended in complete 
DME. In each culture well, 106 CFSE-labeled WT cells were incubated 
with 106 irradiated (2,500 Rad) WT CD4-depleted spleen cells as APC, 
with or without addition of WT or CCR4−/− CD4+CD25+ T reg cells. All 
cultures (except unstimulated control) were stimulated with 3 μg/ml anti-
CD3 and 1 μg/ml anti-CD28 for 110 h. Proliferation of CD4+CD25− 
T cells was measured by assessing relative CFSE dilution by fl  ow cytometry.
Neonatal transfers. CD4+CD25+ T reg cells (>90% purity in all experi-
ments) were isolated from the spleen and LNs of 8–12-wk-old B6.SJL 
(CD45.1+) and CCR4−/− (CD45.2+) as described for the suppression assay. 
Neonatal sf mice (1–2 d old) were given 1–2 × 106 CD4+CD25+ T reg cells 
in 20 μl PBS by intraperitoneal injection. Mice were monitored for external 
signs of infl  ammatory disease and killed between 30 and 50 d after transfer 
for histological and phenotypic analyses.
Online supplemental material. Fig. S1 demonstrates that transferred 
CD4+KJ1-26+ cells maintain Foxp3 expression after immunization in vivo. 
Fig. S2 illustrates that there is an impaired accumulation of CCR4-defi  cient 
CD4+Foxp3− T cells in the skin and lung airways in the WT + CCR4−/− 
mixed BM chimeras. Fig. S3 shows high-magnifi  cation pictures of the der-
mal infi  ltration by lymphocytes, neutrophils, eosinophils, and mast cells in 
CCR4/sf chimeras. Fig. S4 shows the accumulation of sf-derived CD4+ 
T cells in various tissues of two representative CCR4/sf chimeras compared 
with controls. Fig. S5 demonstrates that CCR4−/− T reg cells function nor-
mally in an in vitro suppression assay. Table S1 is a detailed description of the 
histological scoring system used to analyze tissue damage in our experimental 
model. The online version of this article is available at http://www.jem
.org/cgi/content/full/jem.20070081/DC1. 
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